Page
Menu
  Sitemap

Welcome To Sweet Coconut Lime

Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
King HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, Cincotta CM, Subra C, Peachman KK, Hack HR, Chen RE, Thomas PV, Chen WH, Sankhala RS, Hajduczki A, Martinez EJ, Peterson CE, Chang WC, Choe M, Smith C, Headley JA, Elyard HA, Cook A, Anderson A, Wuertz KM, Dong M, Swafford I, Case JB, Currier JR, Lal KG, Amare MF, Dussupt V, Molnar S, Daye SP, Zeng X, Barkei EK, Alfson K, Staples HM, Carrion R, Krebs SJ, Paquin-Proulx D, Karasavvas N, Polonis VR, Jagodzinski LL, Vasan S, Scott PT, Huang Y, Nair MS, Ho DD, de Val N, Diamond MS, Lewis MG, Rao M, Matyas GR, Gromowski GD, Peel SA, Michael NL, Modjarrad K, Bolton DL..
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.
Apostolidis SA, Kakara M, Painter MM, Goel RR, Mathew D, Lenzi K, Rezk A, Patterson KR, Espinoza DA, Kadri JC, Markowitz DM, E Markowitz C, Mexhitaj I, Jacobs D, Babb A, Betts MR, Prak ETL, Weiskopf D, Grifoni A, Lundgreen KA, Gouma S, Sette A, Bates P, Hensley SE, Greenplate AR, Wherry EJ, Li R, Bar-Or A..
Ahimsa and alternatives -- the concept of the 4th R. The CPCSEA in India.
Pereira S, Tettamanti M. Pereira S, et al..
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases.
Subbarayan MS, Joly-Amado A, Bickford PC, Nash KR. Subbarayan MS, et al.. J Clin Invest. 2021 Sep 15;131(18):e143768. doi: 10.1172/JCI143768. J Clin Invest. 2021. PMID: 34523615 Free article.. Roddie C, et al. J Clin Oncol. 2021 Aug 31:JCO2100917. doi: 10.1200/JCO.21.00917. Online ahead of print. J Clin Oncol. 2021. PMID: 34464155. Ren X, et al. Redox Biol. 2021 Oct;46:102122. doi: 10.1016/j.redox.2021.102122. Epub 2021 Aug 31. Redox Biol. 2021. PMID: 34482117

top
Home
Page
Menu